Clinical Trials for Intra-Cellular Therapies

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder

PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects

Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

Caplyta in Borderline Personality Disorder

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease